glp-1 oral liquid dosage for weight loss Foundayo (orforglipron) – First Non-Peptide RA FDA-approved April 2026 chronic management. Once-daily tablet with no fasting requirement, stepwise dosing up to 17.2 mg, and meaningful weight reduction in GLP-1 Oral Tablet — Zera

And today we have a very special episode, and were going to talk about this important topic that JP is going to explain to us from a GHLF perspective, but also more importantly from a patient perspective

It can, however, also cause a reduction in lean muscle mass due to loss of appetite and consequent changes in nutritional intake

IBD is associated with the dysregulation of the symbiotic relationship between the commensal ecosystem and the mucosal immune system ( Crohns disease (CD) and ulcerative colitis (UC) are the two major phenotypes of IBD, and they differ meaningfully in their biology, barrier injury patterns, and epithelial restitution mechanisms

Lifting weights helps build and protect muscle, which is critical during weight loss, when muscle loss is more likely